- Home
- XAIR vs DARE Comparison
XAIR vs DARE Comparison
Compare XAIR & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- DARE
- Stock Information
- Founded
- XAIR 2011
- DARE N/A
- Country
- XAIR United States
- DARE United States
- Employees
- XAIR N/A
- DARE N/A
- Industry
- XAIR Medical/Dental Instruments
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- DARE Health Care
- Exchange
- XAIR Nasdaq
- DARE Nasdaq
- Market Cap
- XAIR 27.7M
- DARE 27.9M
- IPO Year
- XAIR N/A
- DARE N/A
- Fundamental
- Price
- XAIR $0.35
- DARE $3.17
- Analyst Decision
- XAIR Strong Buy
- DARE Strong Buy
- Analyst Count
- XAIR 4
- DARE 4
- Target Price
- XAIR $3.67
- DARE $20.33
- AVG Volume (30 Days)
- XAIR 1.4M
- DARE 23.5K
- Earning Date
- XAIR 02-10-2025
- DARE 03-27-2025
- Dividend Yield
- XAIR N/A
- DARE N/A
- EPS Growth
- XAIR N/A
- DARE N/A
- EPS
- XAIR N/A
- DARE N/A
- Revenue
- XAIR $3,023,000.00
- DARE $1,881,316.00
- Revenue This Year
- XAIR $244.61
- DARE N/A
- Revenue Next Year
- XAIR $258.76
- DARE $136.52
- P/E Ratio
- XAIR N/A
- DARE N/A
- Revenue Growth
- XAIR 338.75
- DARE 88.13
- 52 Week Low
- XAIR $0.30
- DARE $2.67
- 52 Week High
- XAIR $2.11
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- XAIR 41.74
- DARE 50.64
- Support Level
- XAIR $0.34
- DARE $2.95
- Resistance Level
- XAIR $0.40
- DARE $3.31
- Average True Range (ATR)
- XAIR 0.05
- DARE 0.15
- MACD
- XAIR -0.00
- DARE 0.01
- Stochastic Oscillator
- XAIR 10.21
- DARE 61.11
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.